Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
As someone who regularly consumes broadcast and print news, I can confirm that coverage, analysis and opinion pieces on artificial intelligence (AI) are everywhere. AI is coming for our jobs, but it will also happily recommend a new one for us. AI has the potential to accelerate medical and scientific discoveries, enhance education, boost productivity […]
I went down a bit of a rabbit hole the other day, as one often does on the internet and/or social media. In my defence, I was looking for inspiration for my next blog post – this one – and I found some. It started with this parody song about placebos, by anesthetist Dr. Suman […]
Two articles in an August issue of The Globe and Mail caught my attention. The articles were very different – one was in the news section and one was in business – but they converged on a similar theme: women’s health. Women’s health has been under-researched, creating knowledge, data and clinical gaps. Those gaps translate […]
What are peptides and why are they all over traditional and social media? Peptides are chains of molecules called amino acids that link together; they are smaller versions of proteins. Thousands of naturally occurring peptides have been identified in the human body. They perform a wide variety of biological functions, although scientists continue to discover […]
“Regulatory approval does not translate to dollars for a company, nor does it lead to patients being treated. Without reimbursement, all of the efforts of translation and development are lost.” My former colleague, Mark Curtis, wrote these words back when he blogged for Signals and worked as a business development analyst for CCRM. At the […]
Right Turn: Exploring quantum computing and its real-world impact for advanced therapies
As someone who regularly consumes broadcast and print news, I can confirm that coverage, analysis and opinion pieces on artificial intelligence (AI) are everywhere. AI is coming for our jobs, but it will also happily recommend a new one for us. AI has the potential to accelerate medical and scientific discoveries, enhance education, boost productivity […]